Nifurtimox
CAS 23256-30-6Small Molecule
Overview
Nifurtimox is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL290960).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Nifurtimox expires — and exclusivity 6 Aug 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (E)-N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitrofuran-2-yl)methanimine
- Canonical SMILES
- CC1CS(=O)(=O)CCN1/N=C/C2=CC=C(O2)[N+](=O)[O-]
- InChIKey
- ARFHIAQFJWUCFH-IZZDOVSWSA-N
Verified Supplier Partner
Do you supply Nifurtimox? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.